Semiconductor package and method
    51.
    发明授权
    Semiconductor package and method 失效
    半导体封装及方法

    公开(公告)号:US06730989B1

    公开(公告)日:2004-05-04

    申请号:US09596130

    申请日:2000-06-16

    IPC分类号: H01L23544

    摘要: A semiconductor packaging arrangement, or module, includes a printed circuit board having an electrical interconnect thereon and a semiconductor package mounted to the printed circuit board. The semiconductor package includes a fractional portion of a semiconductor wafer having a plurality of integrated circuit chips thereon, such chips being separated by regions in the fractional portion of the wafer. The fractional portion of the wafer has a plurality of electrical contacts electrically connected to the chips. The package also includes a dielectric member having an electrical conductor thereon. The electrical conductor are electrically connected to the plurality of electrical contacts of the plurality of chips to electrically interconnect such plurality of chips with portions of the electrical conductor spanning the regions in the fractional portion of the wafer. A connector is provided for electrically connecting the electrical conductor of the package to the electrical interconnect of the printed circuit board.

    摘要翻译: 半导体封装装置或模块包括其上具有电互连的印刷电路板和安装到印刷电路板的半导体封装。 半导体封装包括其上具有多个集成电路芯片的半导体晶片的分数部分,这些芯片由晶片的分数部分中的区域分隔开。 晶片的分数部分具有电连接到芯片的多个电触点。 封装还包括其上具有电导体的电介质构件。 电导体电连接到多个芯片的多个电触头,以将这些多个芯片与跨越晶片的分数部分中的区域的电导体的部分电互连。 提供一种用于将封装的电导体电连接到印刷电路板的电互连的连接器。

    &bgr;-phenylalanine derivatives as integrin antagonists
    53.
    发明授权
    &bgr;-phenylalanine derivatives as integrin antagonists 失效
    β-苯丙氨酸衍生物作为整联蛋白拮抗剂

    公开(公告)号:US06589972B2

    公开(公告)日:2003-07-08

    申请号:US09867835

    申请日:2001-05-30

    IPC分类号: A01N4350

    CPC分类号: C07C311/19 C07C311/47

    摘要: The present invention relates to compounds of the general formula (1) wherein R4 is —SO2R4′, —COOR4″, —COR4′, —CONR4′2 or —CSNR4′2; R4′ is hydrogen, a substituted or unsubstituted alkyl or cycloalkyl residue, a substituted or unsubstituted aryl residue or a saturated or unsaturated, optionally substituted heterocyclic residue; R4″ is a substituted or unsubstituted alkyl or cycloalkyl residue, a substituted or unsubstituted aryl residue or a saturated or unsaturated, optionally substituted heterocyclic residue; L is a sulphonamide, amide, ether, ester, keto, urea, thioether, sulphoxide or sulphone unit optionally extended by one or two methylene groups; and X is N, O or S; and their physiologically acceptable salts and stereoisomers. The present invention furthermore relates to a process for the preparation of the compounds of the formula (1), a pharmaceutical composition containing at least one of these compounds, and the use of compounds of the formula (1) for the production of a pharmaceutical composition having integrin-antagonistic action and in particular for the therapy and prophylaxis of cancer, osteolytic diseases such as osteoporosis, arteriosclerosis, restenosis and ophthalmic disorders.

    摘要翻译: 本发明涉及通式(1)的化合物,其中R 4是-SO 2 R 4',-COOR 4“,-COR 4', - CONR 4'2或-CSNR 4'2; R 4'是氢,取代或未取代的烷基或环烷基残基,取代或未取代的芳基残基或饱和或不饱和的任选取代的杂环残基; R 4“是取代或未取代的烷基或环烷基残基,取代或未取代的芳基残基或饱和或不饱和的任选取代的杂环残基; L是任选被一个或两个亚甲基延伸的磺酰胺,酰胺,醚,酯,酮,脲,硫醚,亚砜或砜单元; X为N,O或S; 及其生理上可接受的盐和立体异构体。 本发明还涉及制备式(1)化合物的方法,含有这些化合物中的至少一种的药物组合物,以及式(1)化合物在制备药物组合物中的用途 具有整合素拮抗作用,特别是用于治疗和预防癌症,溶骨性疾病如骨质疏松症,动脉硬化,再狭窄和眼科疾病。

    &bgr;-phenylalanine derivatives as integrin antagonists
    54.
    发明授权
    &bgr;-phenylalanine derivatives as integrin antagonists 失效
    β-苯丙氨酸衍生物作为整联蛋白拮抗剂

    公开(公告)号:US06291503B1

    公开(公告)日:2001-09-18

    申请号:US09232738

    申请日:1999-01-15

    IPC分类号: A01N4356

    CPC分类号: C07C311/19 C07C311/47

    摘要: The present invention relates to compounds of the general formula (1) wherein R4 is —SO2R4, —COOR4′, —COR4′, —CONR4′2 or —CSNR4′2; R4′ is hydrogen, a substituted or unsubstituted alkyl or cycloalkyl residue, a substituted or unsubstituted aryl residue or a saturated or unsaturated, optionally substituted heterocyclic residue; R4″ is a substituted or unsubstituted alkyl or cycloalkyl residue, a substituted or unsubstituted aryl residue or a saturated or unsaturated, optionally substituted heterocyclic residue; L is a sulphonamide, amide, ether, ester, keto, urea, thioether, sulphoxide or sulphone unit optionally extended by one or two methylene groups; and X is N, O or S; and their physiologically acceptable salts and stereoisomers. The present invention furthermore relates to a process for the preparation of the compounds of the formula (1), a pharmaceutical composition containing at least one of these compounds, and the use of compounds of the formula (1) for the production of a pharmaceutical composition having integrin-antagonistic action and in particular for the therapy and prophylaxis of cancer, osteolytic diseases such as osteoporosis, arteriosclerosis, restenosis and ophthalmic disorders.

    摘要翻译: 本发明涉及通式(1)的化合物,其中R4是-SO2R4,-COOR4',-COR4',-CONR4'2或-CSNR4'2; R 4'是氢,取代或未取代的烷基或环烷基残基,取代或未取代的芳基残基或饱和或不饱和的任选取代的杂环残基; R 4“是取代或未取代的烷基或环烷基残基,取代或未取代的芳基残基或饱和或不饱和的任选取代的杂环残基; L是任选被一个或两个亚甲基延伸的磺酰胺,酰胺,醚,酯,酮,脲,硫醚,亚砜或砜单元; X为N,O或S; 及其生理上可接受的盐和立体异构体。 本发明还涉及制备式(1)化合物的方法,含有这些化合物中的至少一种的药物组合物,以及式(1)化合物在制备药物组合物中的用途 具有整合素拮抗作用,特别是用于治疗和预防癌症,溶骨性疾病如骨质疏松症,动脉硬化,再狭窄和眼科疾病。

    Reduced voltage input/reduced voltage output tri-state buffers
    55.
    发明授权
    Reduced voltage input/reduced voltage output tri-state buffers 失效
    降低电压输入/降低电压输出三态缓冲器

    公开(公告)号:US06181165B2

    公开(公告)日:2001-01-30

    申请号:US09037289

    申请日:1998-03-09

    IPC分类号: H03K190185

    摘要: There is disclosed a tri-state buffer circuit for receiving an input signal at a buffer input node and transmitting, responsive to a buffer enable signal, an output signal at a buffer output node. The buffer circuit includes an input stage coupled to the buffer input node. The input stage is configured to receive, when the buffer enable signal is enabled, the input signal. The buffer circuit further includes a level shifter stage coupled to the input stage. The level shifter stage is arranged to output, when the buffer enable signal is enabled, a set of level shifter stage control signals responsive to the input signal. A voltage range of the set of level shifter stage control signals is higher than a voltage range associated with the input signal. The buffer circuit also includes an output stage coupled to the level shifter stage. The output stage is configured to output, when the buffer enable signal is enabled, the output signal on the buffer output node responsive to the set of level shifter stage control signals. The voltage range of the output signal is lower than the voltage range of the set of level shifter stage control signals. The output stage decouples the buffer output node from the input stage and the level shifter stage when the buffer enable signal is disabled.

    摘要翻译: 公开了一种三态缓冲电路,用于在缓冲器输入节点处接收输入信号,并响应于缓冲器使能信号,在缓冲器输出节点处发送输出信号。 缓冲电路包括耦合到缓冲器输入节点的输入级。 输入级配置为在使能缓冲器使能信号时接收输入信号。 缓冲电路还包括耦合到输入级的电平移位器级。 电平移位器级被布置为当缓冲器使能信号被使能时,响应于输入信号而输出一组电平移位器级控制信号。 电平移位器级控制信号的电压范围高于与输入信号相关联的电压范围。 缓冲电路还包括耦合到电平转换级的输出级。 输出级被配置为当缓冲器使能信号被使能时,响应于电平移位器级控制信号的集合,输出缓冲器输出节点上的输出信号。 输出信号的电压范围低于电平移位器级控制信号的电压范围。 当缓冲器使能信号被禁止时,输出级将缓冲器输出节点与输入级和电平移位器级分离。

    Method and apparatus for the treatment of hard biological material, such
as hard dental material using lasers
    58.
    发明授权
    Method and apparatus for the treatment of hard biological material, such as hard dental material using lasers 失效
    用于治疗硬生物材料的方法和装置,例如使用激光的硬质牙科材料

    公开(公告)号:US5415652A

    公开(公告)日:1995-05-16

    申请号:US254427

    申请日:1994-06-06

    摘要: A method and apparatus for the ablation of hard biological material, such hard dental material, using a rapidly pulsed laser employ a crystal disposed in the propagation path of the laser radiation, the crystal being disposed at the laser output and serving as an interface with an optical conductor which conveys the laser radiation to the treatment site. The crystal smooths the time/intensity characteristics of the pulsed laser radiation to the extent that transmission to the treatment site using optical wave guides is possible. Additional protective features are provided to prevent the ablated biological material to destroy the exposed optical end surfaces of the treatment applicator. Additional design features improve the ergonomic efficiency of the handpiece and its ability to be sterilized.

    摘要翻译: 使用快速脉冲激光消融硬质生物材料的这种硬质牙科材料的方法和装置采用设置在激光辐射的传播路径中的晶体,该晶体被设置在激光输出处并用作与 将激光辐射传送到治疗部位的光导体。 晶体使脉冲激光辐射的时间/强度特性平滑到使用光波导传输到治疗部位是可能的程度。 提供额外的保护特征以防止烧蚀的生物材料破坏处理涂敷器的暴露的光学端面。 额外的设计特征提高了手机的人体工程学效率及其消毒能力。

    Form generating method and apparatus
    59.
    发明授权
    Form generating method and apparatus 失效
    表格生成方法和装置

    公开(公告)号:US5222211A

    公开(公告)日:1993-06-22

    申请号:US884039

    申请日:1992-05-14

    IPC分类号: G06F17/24

    CPC分类号: G06F17/243

    摘要: A process of controlling the course of a program in form processing by data processing systems for data contents of a form (80, 81, 82) built of fields to be processed. The pictorial illustration (display of the form (80, 81, 82), the reading and fading in of the data relevant for this form, the manipulation of these data by the user and the processing of these data arranged by the user by a firmly assigned form processing program to the form after selection of a form specification. The form processing program is composed here, under predetermination of the actual form specification, according to the available fields, gradually of individual programs which are typical for the field.

    摘要翻译: 由数据处理系统对由要处理的字段构成的表格(80,81,82)的数据内容进行表单处理的程序的过程进行控制的过程。 图示(形式(80,81,82)的显示,与此形式有关的数据的读取和衰落,用户对这些数据的操作以及由用户安排的这些数据的处理 表格处理程序在选择表单规范后以表格形式,表格处理程序在此组合,根据实际表格规范的预先确定,根据可用字段,逐渐对于该领域的典型的各个程序。

    Process for the preparation of elastic polyurethane flexible foams
usable in cold-mold techniques to produce molded articles
    60.
    发明授权
    Process for the preparation of elastic polyurethane flexible foams usable in cold-mold techniques to produce molded articles 失效
    用于制备可用于冷模技术的弹性聚氨酯软质泡沫塑料的制备方法来生产模塑制品

    公开(公告)号:US4668708A

    公开(公告)日:1987-05-26

    申请号:US869199

    申请日:1986-05-30

    IPC分类号: C08G18/10 C08G18/14

    CPC分类号: C08G18/10 Y10S521/914

    摘要: The invention is a process for the preparation of elastic polyurethane flexible foams having densities from approximately 25 to 60 kg/m.sup.3, and producing molded articles in closed molds at temperatures from 25.degree. to 80.degree. C., comprising reacting(A) an organic polyisocyanate prepolymer having an isocyanate content from 6 to 20 percent by weight prepared by reacting a toluene diisocyanate and/or a diphenylmethane diisocyanate with a di- to tetrafunctional polyether polyol having a hydroxyl number from 20 to 50 and oxyethylene terminal group content of at least 10 to 30 percent by weight(B) a mixture of compounds containing reactive hydrogen atoms, comprising a mixture of(a) from 55 to 89.5 parts by weight of at least one di- to tetrafunctional polyether polyol having a hydroxyl number of from 20 to 80 and less than 10 percent by weight terminal oxyethylene groups,(b) from 0.5 to 20 parts by weight of at least one alkanolamine, and(c) from 10 to 25 parts by weight water, in the presence of(C) a blowing agent,(D) a catalyst, and optionally(E) auxiliaries and/or additives.

    摘要翻译: 本发明是制备密度为约25至60kg / m 3的弹性聚氨酯柔性泡沫体的方法,并且在封闭模具中在25℃至80℃的温度下生产模制品,其包括使(A)有机多异氰酸酯 预聚物的异氰酸酯含量为6〜20重量%,其通过使甲苯二异氰酸酯和/或二苯基甲烷二异氰酸酯与羟基数为20至50的二至四官能团聚醚多元醇反应制备,氧乙烯基端基含量为至少10至 30重量%(B)含有反应性氢原子的化合物的混合物,其包含(a)55至89.5重量份的至少一种羟基数为20至80的二官能或四官能团聚醚多元醇的混合物,以及 末端氧乙烯基少于10重量%,(b)0.5至20重量份的至少一种链烷醇胺,和(c)10至25重量份的水, (C)发泡剂,(D)催化剂和任选的(E)助剂和/或添加剂。